title: Clinicopathologic presentations of dermatomycoses in cancer patients.
abstract: Many of the skin fungal infections in cancer patients may look similar to those infections in non-cancer patients. However, in some cases, they become more extensive and even life threatening. Prolonged and severe neutropenia is the main risk factor for the dramatic issue of fungal infections. The dermatomycoses in cancer patients can be classified in four broad groups: primary superficial dermatophytoses, primary superficial yeast infections, opportunistic mold infections with distinct potential for dissemination and secondary cutaneous manifestations of fungaemia. Occasionally, more than one fungus are found inside a given skin lesion. A special condition is represented by the mycotic colonization of mucosal squamous cell carcinomas. Angio-invasion by fungi accounts for the frequency of disseminated infections prevailing in immunocompromised cancer patients. In case of skin involvement, the dermatologist may assist by recognizing subtle semiological signs and performing biopsies for swift histological examination, molecular biology and/or culture.
authors.affiliation: Department of Dermatopathology, University Hospital Sart Tilman, Liège, Belgium. pascale.quatresooz@chu.ulg.ac.be
authors.forename: P
authors.initials: P
authors.lastname: Quatresooz
authors.forename: C
authors.initials: C
authors.lastname: Piérard-Franchimont
authors.forename: J E
authors.initials: JE
authors.lastname: Arrese
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage; D001706:Biopsy; D003881:Dermatomycoses / Q000175:diagnosis* / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D016867:Immunocompromised Host; D009369:Neoplasms / Q000150:complications*; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents